Type 2 diabetes has become one of the fastest-growing health challenges worldwide, affecting millions across all age groups.

Bromocriptine is unique in that it does not have a specific receptor that mediates its action on glucose and lipid metabolism. Rather, its effects are mediated via resetting of dopaminergic and ...

The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million—over four ...

Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate for the ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

Diabetes is the eighth leading cause of death in the US and can lead to other conditions, including kidney failure, ...

The study, backed by the WHO, was released to mark World Diabetes Day on Thursday. It conducts a comparison between the ...

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

A new study found that over 800 million adults have diabetes worldwide — almost twice as many as previous estimates have ...

A new study reveals a staggering 828 million adults globally are living with diabetes, double previous estimates. Over half ...